GlassScriptPhysician profile
Darshan B Patel
NPI 1871955674
$1,082.20
in general payments reported to CMS, 2019-2025
18 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.10 · 2022: $341 · 2023: $87.63 · 2024: $287 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $236.03 | 2022 | |
| Medtronic, INC. | $160.89 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $129.03 | 2022-2024 | Senza |
| Boston Scientific Corporation | $128.64 | 2025 | General - Therapies, Intracept |
| Medtronic USA, INC. | $87.10 | 2020 | |
| Spr Therapeutics, INC | $77.00 | 2024 | Sprint Pns System |
| Curonix LLC | $46.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $34.33 | 2023 | Taltz |
| Fidia Pharma USA INC. | $23.98 | 2022 | |
| Scilex Pharmaceuticals INC. | $22.20 | 2023 | Ztlido |
| Protega Pharmaceutials INC | $21.25 | 2024 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $19.28 | 2025 | |
| Si-Bone, INC. | $19.06 | 2024 | |
| Depuy Synthes Sales INC. | $16.99 | 2025 | Peak, Monovisc, Orthovisc |
| Masimo Corporation | $16.71 | 2023 | Patient Safetynet System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $14.90 | 2025 | Lupkynis |
| Collegium Pharmaceutical, INC. | $14.39 | 2023 | Belbuca |
| Globus Medical, INC. | $13.72 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.